tm logo
ACUITAS THERAPEUTICS
FORMALIZED

on 01 Nov 2022

Last Applicant/ Owned by

ACUITAS THERAPEUTICS INC.

6190 Agronomy RdSuite 405, University of British ColumbiaVancouver

BRITISH COLUMBIA

CA

V6T1W5

Serial Number

2219343 filed on 01st Nov 2022

Correspondent Address

745 Thurlow Street, Suite 2400Vancouver

BRITISH COLUMBIA

CA

V6E0C5

ACUITAS THERAPEUTICS

Trademark usage description

lipids, lipid nanoparticles, lipid formulations, and nucleic acids, including messenger rna, for scientific purposes, research purposes, or laboratory Read More

Classification Information


Class [001]
Lipids, lipid nanoparticles, lipid formulations, and nucleic acids, including messenger RNA, for scientific purposes, research purposes, or laboratory use


Classification kind code

11

Class [005]
Pharmaceutical preparations, such as, drug delivery agents in the nature of lipid nanoparticle carriers that facilitate delivery of pharmaceutical preparations and nucleic acid therapeutics; pharmaceutical preparations comprised of nucleic acids, including messenger RNA, and lipid nanoparticles; pharmaceutical preparations comprised of lipid nanoparticles; pharmaceutical preparations, such as, vaccines for human use; pharmaceutical preparations for gene silencing, for gene editing, for antibody therapeutics, for protein replacement therapeutics, and for nucleic acid therapeutics


Classification kind code

11

Class [042]
Research, development, and evaluation services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, including messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology; synthetic chemistry services, such as, design, synthesis, analysis, evaluation, and biophysical characterization of lipids, lipid formulations, and lipid nanoparticles; preclinical study services, such as, conducting pharmacodynamic and pharmacokinetic studies, safety and tolerability studies regarding clinical pathology and histopathology, immune response characterization studies, and bioanalytical services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, including messenger RNA, drug delivery agents, and nucleic acid therapeutics; clinical research services, such as, chemical molecular analysis, product optimization, and clinical trial services to pharmaceutical industries; research and development of new formulation products for others; research and development of new pharmaceuticals, medical therapies, vaccines, gene therapies, drug delivery agents, and nucleic acid therapeutics for others; project management services for research and development programs in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, including messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology; consultancy services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, including messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology


Classification kind code

11

Class [044]
Medical and veterinary, beauty, agricultural and forestry


Comment text

CIPO Classification Code

Classification kind code

Nice

Class [045]
Regulatory compliance consultancy services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid nanoparticles, nucleic acid, including messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology


Classification kind code

11

Mark Details


Serial Number

2219343

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 287
on 10th Nov 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 01st Nov 2022
Filed
Submitted for opposition 1
on 01st Nov 2022
Created
Submitted for opposition 31
on 01st Nov 2022
Formalized